Asparaginase News and Research

RSS
Asparaginase is a drug which is given at the same time as chemotherapy drugs. It is an enzyme which deprives leukaemia cells of essential nutrients so that they die.
Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Research may lead to potential treatment for deadly bacterial infections

Research may lead to potential treatment for deadly bacterial infections

Research opens way to possible new treatments for bacterial infections

Research opens way to possible new treatments for bacterial infections

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

Study shows children with ALL can safely receive intravenous infusions of chemotherapy

Study shows children with ALL can safely receive intravenous infusions of chemotherapy

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

ERYTECH reports fast take-off of GRASPA Phase IIb trial in patients with acute myeloid leukemia

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

AIBioTech announces implementation of L-asparaginase activity assay for pediatric ALL

Positive results from ERYTECH Pharma asparaginase Phase II trials on ALL

Positive results from ERYTECH Pharma asparaginase Phase II trials on ALL

EUSA Pharma acquires ASPAREC development and commercialization rights

EUSA Pharma acquires ASPAREC development and commercialization rights

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia

EUSA Pharma receives FDA approval for Erwinaze to treat ALL

EUSA Pharma receives FDA approval for Erwinaze to treat ALL

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

NYU Cancer Institute scientists present new research findings at ASCO 2011

NYU Cancer Institute scientists present new research findings at ASCO 2011